Deerfield Management Company, L.P. (Series C) Aziyo Biologics, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.37 Billion
- Q3 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,371,603 shares of AZYO stock, worth $1.99 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,371,603Holding current value
$1.99 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding AZYO
# of Institutions
31Shares Held
16.6MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT3.18MShares$4.62 Million0.19% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.17MShares$4.59 Million0.76% of portfolio
-
Silverarc Capital Management, LLC2.85MShares$4.13 Million0.85% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL2.64MShares$3.83 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$1.71 Million0.0% of portfolio
About AZIYO BIOLOGICS, INC.
- Ticker AZYO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,308,720
- Market Cap $13.5M
- Description
- Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...